Clinical Trial Update: Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial assessed the safety of the combination of panitumumab, irinotecan, and everolimus in patients with advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Everolimus (everolimus)
• Irinotecan (Irinotecan)
• Panitumumab (panitumumab)

Snippet

Sponsor: The Queen Elizabeth Hospital | Conditions: Colorectal Cancer, Colorectal Carcinoma | Phase 1, Phase 2 | Status: COMPLETED